Compare PUBM & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PUBM | INNV |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.5M | 485.4M |
| IPO Year | 2020 | 2021 |
| Metric | PUBM | INNV |
|---|---|---|
| Price | $9.21 | $4.99 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $18.45 | $5.00 |
| AVG Volume (30 Days) | ★ 1.1M | 246.1K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $288,382,000.00 | ★ $884,662,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | $0.49 | $9.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.48 |
| 52 Week Low | $7.01 | $2.60 |
| 52 Week High | $17.32 | $6.26 |
| Indicator | PUBM | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 48.23 |
| Support Level | $8.91 | $4.94 |
| Resistance Level | $9.24 | $5.21 |
| Average True Range (ATR) | 0.35 | 0.44 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 61.62 | 17.42 |
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.